Skip to main content

Finding and characterizing new therapeutic targets and agents

Our research spans activities in contemporary chemical biology and drug discovery and blends the principles and experimental techniques of chemistry and biology with computational science. While maintaining a traditional emphasis on the drug candidate, CBMC integrates contemporary biological methods to merge small molecule and target biomolecule research. This approach allows for elucidation of disease pathways and mechanisms of drug action. CBMC encompasses nearly all aspects of drug discovery, including bioactive natural products, organic chemistry, computational drug design, assay development, high throughput screening of chemical libraries, and studies in living cells.

CBMC has research strengths in the synthesis and structure-activity characterization of pharmaceutically relevant small molecules and natural products; bioorganic and chemical biology studies of the properties of designed small-molecule ligands and their cognate drug targets, including proteins, nucleic acids, and glycoconjugates; combinatorial biochemistry and proteomics for the identification of novel signaling pathways and drug targets; structural biology and biomolecular dynamics of drug-protein interactions; chemo- and bioinformatics; and molecular modeling.

Research Facilities

marsico_hall

Marsico Hall

Marisco Hall is one of the largest buildings on the UNC Chapel Hill campus and houses basic and translational research across several disciplines. The building includes the Marsico Lung Institute, the Biomedical Research Imaging Center, and researchers from UNC Lineberger Comprehensive Cancer Center, nanomedicine, microbiology and immunology, and pharmacoengineering.

Pharmacy researchers with labs in Marsico Hall include members of the UNC Eshelman School of Pharmacy’s Division of Chemical Biology and Medicinal Chemistry, Division of Pharmacoengineering and Molecular Pharmaceutics, Center for Integrative Chemical Biology and Drug Discovery and the Center for Nanotechnology in Drug Delivery.

jeff_aube

Jeff Aubé Lab

The Aubé laboratory uses synthetic chemistry to enable the study of biological pathways and as starting points for drug discovery.

albert_bowers

Albert Bowers Lab

Research in the Bowers Lab is concentrated on the synthesis, assessment, and modification of potential therapeutic leads, especially those derived from natural products.

david_drewry

David Drewry Lab

The Drewry lab in focused on designing, synthesizing, evaluating, and sharing small molecule chemical probes for protein kinases.

kevin_frankowski

Kevin Frankowski Lab

Research in the Frankowski lab uses synthetic chemistry to develop new approaches for the treatment of unmet medical needs.

stephen_frye

Stephen Frye Lab

The Frye lab focuses on chemical biology of chromatin regulation with an emphasis on proteins that bind methylated lysine, and collaborative oncology drug discovery with faculty in the Lineberger Cancer Center.

masuo_goto

Masuo Goto Lab

The Goto lab focuses on chemical biology of cell cycle regulation and multidrug-resistant phenotype in cancer using small molecules inspired by unique natural products.

lauren_haar

Lauren Haar Lab

The Haar lab focuses on investigating the role that refined spatial and temporal control of intracellular signaling cascades can play in the progression of cardiovascular injury. We use a research strategy involving plasmid and optogenetic protein engineering, high content screening, high resolution microscopy and physiologically based cell analysis.

nate_hathaway

Nate Hathaway Lab

The Hathaway lab was established at UNC with a founding idea that the group could make a contribution to understanding dynamic epigenetic processes by using unique chemical biology approaches they pioneered.

lindsey_ingerman_james

Lindsey Ingerman James Lab

The James lab is interested in modulating the activity of chromatin reader proteins with small-molecule ligands, specifically potent and selective chemical probes, in order to open new avenues of research in the field of chromatin biology and potentially translate to compounds of therapeutic value.

mike_jarstfer

Michael Jarstfer Lab

The Jarstfer lab is interested in targeting telomere biology for aging disorders and cancer treatment strategies and exploring the mechanism of oxytocin in controlling social behavior.

dimitri_kireev

Dmitri Kireev Lab

The Kireev lab develops and applies computational tools to advance our understanding of complex biological systems and discover therapies for unmet medical needs.

david_lawrence

David Lawrence Lab

The Lawrence lab works to understand the biochemical processes of the cell by studying them as they happen in the cell as opposed to studying them in vitro.

andrew_lee

Andrew Lee Lab

Andrew Lee studies the role of conformational dynamics in protein function, conformational changes, enzyme catalysis, drug binding, and allostery. His laboratory uses a variety of biophysical and biochemical tools, especially NMR spectroscopy.

jian_liu

Jian Liu Lab

Research in the Jian Liu group is focused on glycobiology and glycobiochemistry, an emerging field that emphasizes the biological functions of carbohydrates.

rihe_liu

Rihe Liu – Biological Therapeutics Lab

The Liu laboratory’s research interests focus on the development and application of novel drug target-binding affinity molecules by integrating directed molecular selection and evolution, ligand design and engineering, in vitro cellular and signaling characterization, and in vivo therapeutic efficacy studies in tumor mouse models.

robert_mcginty

Robert McGinty Lab

The McGinty lab studies molecular mechanisms of chromatin signaling. By pairing atomic precision protein chemistry with high resolution structural biology, they aim to understand how the nucleosome functions as a signaling hub for gene expression, DNA replication, and DNA damage repair in development and disease.

susan_natschke

Susan Morris-Natschke Lab

The Morris-Natschke laboratory focuses on natural product chemistry in collaboration with the Natural Products Research Laboratories at UNC.

kh_lee

Natural Products Research Laboratories

The K.H. Lee Natural Products Research Laboratories (NPRL) engage in research using medicinal chemistry-based methods to discover new drugs from herbal medicines, particularly Traditional Chinese Medicine.

samantha_pattenden

Samantha Pattenden Lab

The Pattenden lab develops innovative techniques in chromatin-based therapeutic target discovery and cancer diagnostics.

ken_pearce

Kenneth Pearce Lab

The Pearce lab utilizes numerous methods for conducting early drug and chemical probe discovery research.

bryan_roth

Bryan Roth Lab

Bryan Roth, PhD, MD, is a professor in the Division of Chemical Biology and Medicinal Chemistry and in the Department of Pharmacology.

alexander_tropsha

Alexander Tropsha Lab

Alexander Tropsha’s lab develops new methodologies, software tools and applications in the areas of computer-assisted drug design, chemical toxicology, materials informatics, text mining, and health care informatics.

xiaodong_wang

Xiaodong Wang Lab

The Wang lab is interested in developing drug leads/candidates for kinase, phosphate kinase and protein targets identified by UNC faculty and external investigators.

tim_willson

Tim Willson Lab

The Willson laboratory is home to the US site of the SGC, an open science consortium that accelerates research on the lesser studied regions of the genome.

Qisheng Zhang

Qisheng Zhang Lab

The Zhang lab studies lipid signaling pathways that are involved in human disease by developing novel chemical probes and technologies.

The nine-story, 340,000-square-foot building features world-class imaging equipment, including a hybrid MRI/PET whole body scanner, a 7-Tesla MRI whole body scanner and a cyclotron. UNC and Massachusetts General Hospital, in affiliation with Harvard University, are currently the only two academic medical centers in the country that have these three imaging devices in one location. Together, each device optimizes the capabilities of the others, making these devices some of the most powerful diagnostic imaging tools in the world.

  • High-resolution liquids NMR facility (400 MhZ and 500 MHz spectrometers)
  • Digital imaging and photodocumentation equipment
  • Phosphorimaging
  • Molecular graphics workstations
  • Scintillation and gamma counters
  • Microplate readers and automated liquid handling devices for HTS
  • Steady- and transient-state spectrofluorimetry
  • Tissue culture
  • HPLC and FPLC devices
  • Combinatorial synthesis and automated purification
  • Oligonucleotide Synthesis Cores (2)
  • Protein Synthesis/Sequencing Cores (2)
  • DNA Sequencing Core
  • Tissue Culture Core
  • Flow Cytometry Core
  • Structural Biology Core
  • Mass Spectrometry Core
  • Digital Video Microscopy Core
  • Transgenic and Homologous Recombination Core
  • Molecular Modeling / Computer Graphics Core
  • Macromolecular Interactions Facility

Research Centers and Programs

Center for Integrative Chemical Biology and Drug Discovery (CICBDD)
A multi-disciplinary group that provides an innovative and sustainable scientific force in the creation of chemical probes, drug candidates, assay technologies, and computational approaches to advance understanding of biological mechanisms and place UNC at the forefront of translational medicine.  Also serves to help train students and postdoctoral fellows to enable development of the next generation of drug discovery scientists.

Natural Products Research Laboratories
The NPRL team engages in research using medicinal chemistry-based methods to discover new drugs from herbal medicine, particularly Traditional Chinese Medicine.


Collaboration and Partnership

We are partnering across the campus, state, nation and around the world to advance research and advance knowledge and treatment for patients to discover solutions for the world’s most challenging health issues.

UNC Health Sciences Campus

The School is part of the University of North Carolina at Chapel Hill, a major research university with a large teaching hospital and schools of medicine, public health, nursing, and dentistry.

  • Ranked 5th nationally for federal research among all universities
  • $1.1 billion in sponsored research from all sources annually
  • Eleventh largest research university in research volume and annual expenditures

CBMC’s scientific interests are integrated into UNC’s biomedical sciences. Our students and faculty collaborate with researchers in the UNC School of Medicine, the Lineberger Comprehensive Cancer Center, and many departments across our health sciences campus.


 

Eshelman Institute for Innovation_logo

Eshelman Institute for Innovation

The Eshelman Institute for Innovation was established in 2014 with a $100 million commitment from Dr. Fred Eshelman.  The Institute encourages collaborations between universities, research institutions, foundations and industry that accelerate groundbreaking science from the bench to the patient by funding and translating ‘top tier’ scientific solutions to the market with speed.  Learn more here.

Learn More


rtp_logo

Research Triangle Park

UNC anchors one corner of North Carolina’s famed Research Triangle Park, which hosts an abundance of pharmaceutical, biotech, and health-care companies. This environment offers many opportunities for collaboration in research, education, and patient care with partners in academia, industry, and health care.


Pinnacle-Hill-Logo

Pinnacle Hill

The University of North Carolina at Chapel Hill and Deerfield Management have entered into a partnership to create Pinnacle Hill, a company seeking to discover new medicines to address the significant unmet medical needs of our times. Deerfield will invest up to $65 million of targeted funding through Pinnacle Hill, as well as providing significant drug development expertise to advance promising therapeutic research at UNC-Chapel Hill.  Learn more here.

Learn More


 

PharmAlliance_logo

PharmAlliance

PharmAlliance is a unique international partnership between three global leaders in pharmacy education, the University of North Carolina at Chapel Hill, Monash University, and University College   London. PharmAlliance partners work collaboratively to inspire and train tomorrow’s professional leaders and practitioners to transform education delivery and address major research challenges in pharmacy and the pharmaceutical sciences.

Learn More


SGC+logo

Structural Genomics Consortium

The SGC (Structural Genomics Consortium) is a not-for-profit, public-private partnership that performs basic science of relevance to drug discovery. Research is conducted at several sites around the world to produce reagents, proteins, antibodies, assays, and data that support exploration of the human genome. All material and intellectual output of the SGC is placed in the public domain for use without restriction. The first SGC laboratory to operate in the USA is located in the UNC Eshelman School of Pharmacy. Learn more here.

Learn More